| | Sec. C-6. 22 MRSA §3174-G, sub-§1-C, as enacted by PL 2001, c. 650, | §3, is amended to read: |
|
| | 1-C. Prescription drug waiver program. Except as provided in | paragraph G, the department shall apply to the federal Centers | for Medicare and Medicaid Services for a waiver or amend a | pending or current waiver under the Medicaid program authorizing | the department to use federal matching dollars to enhance the | prescription drug benefits available to persons who qualify for | the elderly low-cost drug program established under section 254 | 254-D. The program created pursuant to the waiver is the | prescription drug waiver program, referred to in this subsection | as the "program." |
|
| A. As funds permit, the department has the authority to | establish income eligibility levels for the program up to | and including 200% of the federal nonfarm income official | poverty level, except that for individuals in households | that spend at least 40% of income on unreimbursed direct | medical expenses for prescription medications, the income | eligibility level is increased by 25%. |
|
| B. To the extent reasonably achievable under the federal | waiver process, the program must include the full range of | prescription drugs provided under the Medicaid program on | the effective date of this subsection and must limit | copayments and cost sharing for participants. If cost | sharing above the nominal cost sharing for the Medicaid | program is determined to be necessary, the department may | use a sliding scale to minimize the financial burden on | lower-income participants. |
|
| C. Coverage under the program may not be less beneficial to | persons who meet the qualifications of former section 254 | than the coverage available under that section on September | 30, 2001. |
|
| D. In determining enrollee benefits under the program, to | the extent possible, the department shall give equitable | treatment to coverage of prescription medications for | cancer, Alzheimer's disease and behavioral health. |
|
| E. The department is authorized to provide funding for the | program by using funds appropriated or allocated to provide | prescription drugs under sections 254 254-D and 258. |
|
| | Sec. C-7. 24-A MRSA §5002-B, sub-§2-A, as enacted by PL 2001, c. 410, | Pt. B, §7, is amended to read: |
|
|